The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - H3 Biomedicine; Janssen; Rainier Therapeutics
Research Funding - AstraZeneca; Rainier Therapeutics
Patents, Royalties, Other Intellectual Property - Patents pending
SWOG S1314: A randomized phase II study of co-expression extrapolation (COXEN) with neoadjuvant chemotherapy for localized, muscle-invasive bladder cancer with overall survival follow up.
 
Thomas W. Flaig
Leadership - Aurora Oncology
Stock and Other Ownership Interests - Aurora Oncology
Consulting or Advisory Role - Janssen Oncology; Seagen
Research Funding - Agensys; Aragon Pharmaceuticals; Astellas Pharma; astrazeneca/MedImmune; Bavarian Nordic; Bristol-Myers Squibb; Dendreon; Exelixis; GTx; Janssen Oncology; La Roche-Posay; Lilly; Medivation; Merck; Novartis; Pfizer; Roche/Genentech; Sanofi; Seagen; Seagen; Sotio; Tokai Pharmaceuticals
Patents, Royalties, Other Intellectual Property - The University of Colorado has filed 2 patents related in which I am an inventor. These are related to early-stage bladder cancer treatment and detection. Neither is commercialized or licensed at this time.
 
Catherine Tangen
No Relationships to Disclose
 
Siamak Daneshmand
Stock and Other Ownership Interests - Taris
Honoraria - Aduro Biotech; Allergan (I); Bristol-Myers Squibb; Ferring; Janssen; Johnson & Johnson; Nucleix; Olympus; pacific edge; Photocure; QED Therapeutics; Seagen; Spectrum Pharmaceuticals
Consulting or Advisory Role - Ferring; Photocure; QED Therapeutics; Taris
Research Funding - Photocure
Travel, Accommodations, Expenses - Photocure
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; BMS; Merck; Pfizer
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Harpoon Therapeutics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck
 
M. Scott Lucia
Stock and Other Ownership Interests - 3D Biopsy
Consulting or Advisory Role - MDxHealth
 
David McConkey
No Relationships to Disclose
 
Dan Theodorescu
Consulting or Advisory Role - Machavert Pharmaceuticals; UroGen pharma
Patents, Royalties, Other Intellectual Property - University of Colorado, Denver (Ral GTPase inhibitors patent that I'm an inventor on)
 
Amir Goldkorn
Research Funding - Angle; Clearbridge Biomedics; Cynvenio Biosystems; Menarini Silicon Biosystems; RareCyte; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor on a patent held jointly by USC and Caltech for a microfilter we developed for capturing live circulating tumor cells from blood.
 
Matthew I. Milowsky
Consulting or Advisory Role - Loxo/Lilly
Research Funding - Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst); Syndax (Inst)
Other Relationship - Elsevier
 
Rick Bangs
Consulting or Advisory Role - Bristol-Myers Squibb
Other Relationship - ASCO; Bladder Cancer Advocacy Network; Facing our Risk of Cancer Empowered; Facing our Risk of Cancer Empowered; Institute for Clinical and Economic Review; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Cancer Institute; National Comprehensive Cancer Network; SWOG; SWOG; SWOG; University of Puerto Rico; University of Puerto Rico; University of Puerto Rico
 
Gary R. MacVicar
No Relationships to Disclose
 
Bruno R. Bastos
Consulting or Advisory Role - AstraZeneca; Bayer; Dendreon; Genzyme; Regeneron
Speakers' Bureau - Sanofi/Regeneron; Seattle Genetics/Astellas
Research Funding - Actuate Therapeutics (Inst); Altor BioScience (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Tempest Therapeutics (Inst); Tolero Pharmaceuticals (Inst); US Oncology (Inst)
 
Jared Fowles
No Relationships to Disclose
 
Daniel Gustafson
No Relationships to Disclose
 
Melissa Plets
No Relationships to Disclose
 
Ian Murchie Thompson
Consulting or Advisory Role - Magforce; Profound Medical
Research Funding - MagForce
Patents, Royalties, Other Intellectual Property - I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Seth P. Lerner
Stock and Other Ownership Interests - C2i genomics
Honoraria - Annenberg Center for Health Sciences at Eisenhower (ACHS); Clinical Care Options; Grand Rounds in Urology; Ology Medical Education; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; C2i Genomics; FerGene; Ferring; Merck Sharp & Dohme; Pfizer/EMD Serono; Roche/Genentech; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; Urogen pharma; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate